Facebook (FB) gets a Bump in its Price Target

183
Facebook Inc (NASDAQ:FB)
Facebook Inc (NASDAQ:FB)

EPS was beaten by Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by a value of $0.04 whereas its guide for its fiscal year 2014 exceeded consensus. Shares of Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) kicked off day’s trading at $155.06; the stock went up as high as $169.98; it closed at a value of $162.00. Weekly performance of ALXN is 17.44%.

EPS was beaten by Facebook Inc (NASDAQ:FB) by a value of $0.04; Jefferies raised the the stock’s price target from a value of $60 to a value of $80; Credit Agricole bumped the price target from $70 to $75 whereas Wedbush bumped the price target from $72.50 to $80. Shares of Facebook Inc (NASDAQ:FB) went up as high as $62.50 during the day after kicking the session off at $62.12; the stock closed at a value of; FB’s range over the day was between $60.46 and $62.50. Stock’s total market cap is marked at $149.94 billion whereas its share volume during the session was 150.44 million as compared to its average share volume 66.84 million.

Twitter Inc (NYSE:TWTR) and Social/online media related names higher following FB results (LNKD also higher). Shares of Twitter Inc (NYSE:TWTR) kicked off the trading session at $63.98 and went up as high as $65.24; after dipping by 6.76% the stock closed at a value of $63.47. Weekly performance of Twitter Inc (NYSE:TWTR) was 1.07%.

 

Comments